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Abstract
Osterix (Osx) is an osteoblast-specific transcription factor required for osteoblast differentiation from mesenchymal stem
cells. In Osx knock-out mice, no bone formation occurs. The vitamin D receptor (VDR) is a member of the nuclear hormone
receptor superfamily that regulates target gene transcription to ensure appropriate control of calcium homeostasis and
bone development. Here, we provide several lines of evidence that show that the VDR gene is a target for transcriptional
regulation by Osx in osteoblasts. For example, calvaria obtained from Osx-null embryos displayed dramatic reductions in
VDR expression compared to wild-type calvaria. Stable overexpression of Osx stimulated VDR expression in C2C12
mesenchymal cells. Inhibition of Osx expression by siRNA led to downregulation of VDR. In contrast, Osx levels remained
unchanged in osteoblasts in VDR-null mice. Mechanistic approaches using transient transfection assays showed that Osx
directly activated a 1 kb fragment of the VDR promoter in a dose-dependent manner. To define the region of the VDR
promoter that was responsive to Osx, a series of VDR promoter deletion mutants were examined and the minimal Osx-
responsive region was refined to the proximal 120 bp of the VDR promoter. Additional point mutants were used to identify
two GC-rich regions that were responsible for VDR promoter activation by Osx. Chromatin immunoprecipitation assays
demonstrated that endogenous Osx was associated with the native VDR promoter in primary osteoblasts in vivo.
Cumulatively, these data strongly support a direct regulatory role for Osx in VDR gene expression. They further provide new
insight into potential mechanisms and pathways that Osx controls in osteoblasts and during the process of osteoblastic cell
differentiation.
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Introduction
Bone formation is a developmental process involving the
differentiation of mesenchymal stem cells to osteoblasts. It involves
two processes: intramembranous and endochondral ossification.
The vast majority of bones in the mammalian skeleton form by
endochondral ossification which requires a cartilagenous template
for osteoblast-directed mineral deposition. Fewer bones, particu-
larly those in the skull, form by intramembranous ossification, a
process in which mineralized bone forms directly from mesenchy-
mal condensations. Osteoblast differentiation from mesenchymal
stem cells occurs through a multi-step molecular pathway
regulated by a complexity of transcription factors and signaling
proteins, including Indian Hedgehog (Ihh), Runx2, Osterix (Osx),
and Wnt signaling pathway proteins [1]. Ihh is required for
endochondral ossification and is needed for the activation of
Runx2 [2]. Both endochondral and intramembranous ossification
require Runx2 which is involved in the differentiation of
mesenchymal cells into preosteoblasts [3]. Osx is a downstream
gene of Runx2. It is specifically expressed in osteoblasts and at low
levels in prehypertrophic chondrocytes [4]. Osx is essential for the
commitment of preosteoblastic cell differentiation into mature
osteoblasts. Wnt signaling plays a role in bone differentiation and
proliferation. The Wnt pathway is important for bone mass
determination in the adult bone. This pathway affects different
stages of bone formation and bone metabolism [5,6].
Osxisanosteoblast-specifictranscriptionfactorrequiredforbone
formation and osteoblast differentiation. Osx knock-out mice
completely lack mineralized bone while cartilagenous tissue is
essentially normal [4]. Osx-null mouse embryos do not express
osteoblast differentiation markers, such as osteocalcin (OC), alkaline
phosphatase (ALP), and others. Osx is reported to inhibit the Wnt
signaling pathway, suggesting a possible mechanism through which
Osx inhibits osteoblast proliferation [7]. It is suggested that Osx
coordinates both osteoblast differentiation and osteoblast prolifer-
ation during bone formation. Our recent observation that Osx
inhibits the Wnt signaling pathway highlights the potential for novel
feedback control mechanisms involved in bone formation.
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26504The vitamin D receptor (VDR) is the nuclear hormone receptor
of the vitamin D endocrine system whose principal role is to
maintain calcium and phosphate homeostasis. The bioactive,
hormonal ligand for VDR is 1,25-dihydroxyvitamin D3 [1,25-
(OH)2D3]. Thus, VDR functions as a ligand-induced nuclear
transcription factor to regulate the expression of genes in critical
mineral-regulating target tissues such as the intestine, kidney,
parathyroids, and bone in order to maintain appropriate mineral
homeostasis. Both humans and mouse models that lack functional
VDR display severe hypocalcemia, hypophosphatemia, rickets and
osteomalacia highlighting a physiological significance of VDR in
maintaining skeletal integrity [8,9,10]. Dietary calcium supple-
mentation prevents the development of the undermineralized
skeletal phenotype in humans with defective VDR and in VDR-
null mice [11,12] indicating that the role of VDR in bone is
indirect or secondary to its role in maintaining appropriate
intestinal and renal handling of calcium. Importantly, numerous
studies also strongly support a direct role for VDR/1,25-(OH)2D3
in the osteoblast where one of its principal effects is to stimulate
RANKL production and osteoblast-mediated osteoclastogenesis
[13,14]. Numerous bone-selective extracellular matrix proteins
such as osteocalcin and osteopontin are VDR target genes [15,16].
1,25-(OH)2D3 is known to have pleotropic, direct effects on
osteoblast differentiation, inhibiting differentiation at the early
stages and promoting late stage osteoblast differentiation [17]. The
expression levels of VDR may be key in this regard and are
highlighted by the osteoblast-directed transgenic expression of
VDR [18,19]. These mice show an increase in cortical and
trabecular bone suggesting an anabolic function under conditions
of high order VDR expression in osteoblasts. Thus, an
understanding of the systems and pathways governing VDR
expression levels in osteoblasts may help uncover the basis for
pleotropism of VDR/1,25-(OH)2D3 in osteoblast function.To
identify the possible downstream targets of Osx, we performed
quantitative real-time RT-PCR to compare RNA levels of
different genes between wild type and Osx knock-out mice. In
this current study, quantitative real-time RT-PCR results
demonstrate that VDR expression is suppressed in the absence
of Osx, and enhanced when Osx is overexpressed. This suggests
that Osx may control VDR gene expression. Additional evidence
from this study indicates that Osx targets the VDR gene promoter
Figure 1. Osx ablation reduces VDR gene expression in vivo. Calvaria RNAs were isolated from E18.5 Osx wild-type and Osx-null embryos. RNA
expression levels for Osx, osteocalcin (OC), Runx2 and VDR were analyzed by real-time RT-PCR. The level of each RNA from Osx-null calvaria was
normalized to a value of 1. *: A star indicates statistical significance compared to Osx wild type group.
Figure 2. Overexpression of Osx activates VDR gene expres-
sion in C2C12 mesenchymal cells. (A) Western immunoblot analysis
of the Dox-regulated Osx-expressing C2C12 cells. Osx expression is
turned on in the absence of Dox. Beta-actin was used as a loading
control. (B) VDR mRNA levels in a stable, Tet-off C2C12 mesenchymal
cell line. RNA was obtained from cultures treated with or without
Doxycycline. Osx expression is induced in the absence of Doxycycline in
this line. VDR mRNA levels were quantitated by real-time RT-PCR. The
VDR RNA level obtained from the cells cultured with Dox was
normalized to a value of 1. Values are presented as the mean 6S.D.
(C) RNA expression level for the osteoblastic marker gene alkaline
phosphatase (ALP). (D) RNA expression level for osteoblastic gene
osteocalcin (OC). Conditions are identical to those described in panel B.
A paired t-test was performed comparing Dox (2) and Dox (+) groups.
*: A star indicates statistical significance compared to Dox (+) group.
doi:10.1371/journal.pone.0026504.g002
Osx Regulates VDR Positively
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which Osx controls osteoblast activity.
Methods
Animals and Genotyping
Wild type and Osx-null mice are on a C57BL genetic
background. All mice were bred and maintained in a specific
pathogen-free facility. Mice were genotyped using genomic DNA
isolated from the tails as previously described [4]. VDR-null mice
were generously provided by M. Demay (Massachusetts General
Hospital and Harvard Medical School, Boston, MA). This line of
mice is on a homogeneous C57BL/6 genetic background. Mouse
genotyping was performed with tail DNA as previously described
[20]. All research protocols related to the VDR-null model were
approved by the Institutional Animal Care and Use Committee of
Case Western Reserve University, where this study was conducted.
The animal protocol number is 2008-0017.
RNA isolation and real-time RT-PCR
Total RNA was purified from the calvaria of E18.5 wild type
and Osx-null mouse embryos with TRIzol reagent (Invitrogen)
with additional purification using an RNeasy mini kit (Qiagen).
Total RNA from C2C12 cells was isolated directly using an
RNeasy Mini Kit according to the manufacturer’s protocols
(Qiagen). RNA was subjected to quantitative real-time RT-PCR,
using the TaqMan One-Step RT-PCR Master Mix reagent
(Applied Biosystems). Relative transcript levels were analyzed by
real-time PCR in a 20 ml reaction volume on 96-well plates, using
an ABI 7500 real-time PCR system (Applied Biosystem).
Transcript levels were normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) levels. All reactions were done in
duplicate and all experiments were repeated at least three times.
Plasmid constructs and subcloning
Subcloning was performed as previously described with
modifications [21]. Progressive deletion fragments of the VDR
promoter region were generated by PCR using mouse genomic
DNA as a template and subcloned into the XhoI and MluI sites of
the pGL-3 vector. Primer sequences were designed based on the
published sequence of the murine VDR promoter and transcrip-
tional start site [22]. Primers were obtained from Integrated DNA
Technologies (IDT) (Coralville, IA). The primer sequences were as
follows: 1) VDR-Xho-3 59GCG CCT CGA GAC AAG CAG
AGA CTG CTC AGC AC, 2) VDR-Mlu-1K 59 GCG CAC GCG
TAC TAA CCG CCA GGC TGG GCT CTC ATC, 3) VDR-
Mlu-500 59GCG CAC GCG TCC TCC AAT CTG GTT TTC
TTG G, 4) VDR-Mlu-250 59GCG CAC GCG TAC GTG GAT
TTG CAC ACA CGA C, 5) VDR-Mlu-120 59GCG CAC GCG
TGT CAA GAA AGT TTC AGG GCT TC. Point mutations
were introduced in the VDR-120 promoter construct using the
QuickChange site-directed mutagenesis kit (Stratagene) and the
following primers: 1) VDR-M1-1 59GCG GTC CGG GAA CAA
AAC CTT GCG GGG GCG GGG CCA GGT GCT GAG, 2)
VDR-M1-2 59 CTC AGC ACC TGG CCC CGC CCC CGC
AAG GTT TTG TTC CCG GAC CGC, 3) VDR-M2-1 59GCG
GTC CGG GGG CGG GGC CTT GCG GGA ACA AAA CCA
GGT GCT GAG, 4) VDR-M2-2 59 CTC AGC ACC TGG TTT
TGT TCC CGC AAG GCC CCG CCC CCG GAC CGC. All
deletion and mutant constructs were verified by DNA sequencing.
Cell culture and transient transfection assay
HEK293 cells (ATCC) were cultured in high glucose Dulbec-
co’s modified Eagle’s medium (GIBCO) supplemented with 10%
fetal bovine serum and 100 units/ml penicillin plus 100 mg/ml
streptomycin at 95% air/5% CO2 humidified incubator. Cells
were plated in 12-well plates, cultured to 60–80% confluence and
transfected with FuGENE 6 (Roche) according to the manufac-
Figure 3. SiRNA-directed knockdown of Osx impairs VDR gene
expression in MC3T3 osteoblasts. (A) RNA expression levels as
determined by quantitative real-time RT-PCR. MC3T3 osteoblasts were
transfected with siRNA targeting mouse Osx. RNA was isolated 24 h
post-transfection and quantitated by real-time RT-PCR. The RNA level
from the control siRNA group was normalized to a value of 1. Values
were presented as the mean 6S.D. A paired t-test was performed
comparing si-control group and si-Osx group. (B) Western analysis of
the Osx knockdown. Protein was isolated by acetone precipitation of
whole cell lysates and then analyzed by western blot using rabbit anti-
VDR or anti-Osx polyclonal antibodies. Beta-actin was used as a loading
control.
doi:10.1371/journal.pone.0026504.g003
Osx Regulates VDR Positively
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promoter luciferase reporter, an Osx expression plasmid (pEX-
Osx) as indicated, and 25 ng of pSV2-beta-gal. After transfection,
cells were incubated for 24 h before harvest. The reporter assays
were analyzed with a BD Monolight system (BD Biosciences).
Luciferase activity was normalized to b-galactosidase activity. All
transfection experiments were repeated at least three times. Values
were presented as the mean 6 standard deviation (S.D.). MC3T3
cells (ATCC) were cultured in Alpha Minimum Essential Medium
with ribonucleosides, deoxyribonucleosides, 2 mM L-glutamine
and 1 mM sodium pyruvate, but without ascorbic acid (GIBCO),
and supplemented with 10% FBS and penicillin plus streptomycin.
For MC3T3 osteoblast differentiation experiments, osteogenic
factors were added into the medium, including BMP2 (300 ng/
ml), ascorbic acid (50 mg/ml) and b–glycerophosphate (10 mM).
This differentiation medium was changed every three days. Stable
C2C12 mesenchymal cells expressing Osx were generated with the
pTet-off Advanced Inducible Gene Expression System (Clontech)
as previously described [7]. C2C12 cells were cultured in
Dulbecco’s modified Eagle’s medium with the following additives
to maintain selection and control Osx expression; G418 (200 mg/
ml), hygromycine (150 mg/ml), and with or without doxycycline
(Dox, 20 ng/ml). Osx expression was induced by the addition of
media lacking doxycycline, a member of the tetracycline group of
antibiotics.
siRNA interference
MC3T3 cells were transfected with siRNA directed against
mouse Osx and C2C12 cells were transfected with siRNA directed
against mouse VDR using Lipofectamine 2000. siRNA oligos were
purchased from Thermo Scientific Dharmacon, and siGENOME
Lamin A/C Control siRNA was used as a non-specific control.
Cells were cultured in 6-well plates. Cells were plated in 1 ml of
growth medium without antibiotics 1 day prior to transfection and
the cells were 30–50% confluent at the time of transfection. The
final siRNA concentration was 100 nM and each well received
100 ml of the siRNA:Lipofectamine. 2000 complex in Opti-MEM
I medium.
Protein purification and Western blot
Protein was isolated by acetone precipitation from the RNeasy
cell lysates according to the manufacturer’s protocol (QIAGEN).
The protein pellet was dissolved in 1% SDS buffer, warmed for
15 min at 55uC, and centrifuged for 5 min at 14000 rpm. Protein
concentrations in the supernatant were determined using a BCA
Protein Assay Kit (Pierce). Proteins were separated on 10% SDS-
PAGE gels and transferred to a PVDF membrane followed by
Western blot analysis. Briefly, 3% milk in TBS containing 0.1%
Tween-20 was used to block non-specific binding. The blot was
subsequently incubated with an anti-VDR rabbit polyclonal
antibody (1:200, Abcam), an anti-ALP rabbit polyclonal antibody
(1:100, Santa Cruz Biotechnology), an anti-OC rabbit polyclonal
antibody (1:100, Santa Cruz Biotechnology) or an anti-Osx rabbit
polyclonal antibody (1:200, Santa Cruz Biotechnology) followed
by a secondary antibody (peroxidase-conjugated anti-rabbit IgG
1:5000, Sigma). After each antibody incubation, blots were
extensively washed in TBS containing 0.1% Tween-20. For
detection, the ECL kit (Amersham Life Sciences) was used
according to the directions of the manufacturer.
Chromatin immunoprecipitation (ChIP) assay
The Chromatin Immunoprecipitation (ChIP) Assay Kit was
from Millipore. ChIP assays were performed as previously
described [23] with some modifications. Briefly, calvarial cells
were isolated from wild-type newborn mice, and were cultured in
Figure 4. VDR ablation has no effect on Osx gene expression in
vivo. Calvarial RNAs were isolated from E18.5 wild-type or VDR-null
embryos. RNA levels for VDR and Osx were analyzed by real-time RT-
PCR. The level of each RNA from wild type calvaria was normalized to a
value of 1 shown in the mean6S.D. A paired t-test was performed
comparing wild-type and VDR-null group.
doi:10.1371/journal.pone.0026504.g004
Figure 5. Osx activates the VDR promoter in a dose-dependent
manner. HEK293 cells were transfected with a 1 kb VDR promoter-
luciferase reporter gene without or with increasing amounts of an Osx-
expression plasmid as indicated. Luciferase activity was normalized by
b-galactosidase activity. Values are presented as the mean 6S.D.
doi:10.1371/journal.pone.0026504.g005
Osx Regulates VDR Positively
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26504DMEM supplemented with 10% FBS. Formaldehyde was used to
cross link the cells for 10 min, and crosslinking was quenched with
glycine. Cells were harvested, rinsed with PBS, and cell pellets
were resuspended in 1 ml of lysis buffer. After sonication, 100 mlo f
sheared chromatin was diluted to 1 ml with IP dilution buffer for
each immunoprecipitation. The chromatin solution was pre-
cleared with 60 ml of protein G Agarose beads at 4uC for 1 hr. The
pre-cleared chromatin was collected and incubated at 4uC
overnight with 5 mg of anti-Osx antibody or IgG as a negative
control. Anti-Osx antibody was created by immunizing rabbits
with a 14-amino acid peptide (AHGGSPEQSNLLEI) located at
the C-terminus of the Osx polypeptide. The antiserum was
affinity-purified over a 3 M Emphaze Biosupport Medium AB1
column (Pierce) coupled to the 14-amino acid peptide and was
eluted. It was then dialyzed against Tris-buffered saline. The
immune complexes were precipitated with 60 ml of protein G
Agarose beads at 4uC for 1 hr. The antibody-protein-DNA
immunocomplexes were washed and subsequently eluted twice
with 100 ml of elution buffer. Formaldehyde cross-linking was
reversed by heating at 65uC overnight with the addition of 5 M
NaCl. All the samples were digested with RNase A and proteinase
K. The DNA was purified using spin columns, and analyzed by
real time PCR. The primer sets used for amplification of VDR
promoter regions were obtained from IDT, and the sequences
were as follows: Primer Set 1, VDR-1: 59TAC TGT TCC ACG
GAA GGC AGA C and VDR-2: 59 ACA AGC AGA GAC TGC
TCA GCA G; Primer Set 2, VDR-D-1: 59 TGG CCG AGT TAC
AGA ATT CC and VDR-D-2: 59 CAT GTG CCA GAT CCT
CTG TG. Data were normalized using GAPDH.
Statistical Analysis
All experiments were repeated a minimum of 3 times. Data was
reported as the mean 6 standard deviation (S.D.). Comparisons
were made between groups by Student’s t test with p,0.05 being
considered as statistically significant.
Results
VDR expression is reduced in the absence of Osx
To identify possible downstream targets of Osx in the
developing mouse skeleton, we performed quantitative real-time
RT-PCR on RNA from wild type and Osx knockout mice in order
to compare RNA levels of several genes. RNA was isolated from
calvaria of E18.5 mouse embryos. As shown in Fig. 1, Osx
expression was readily detected in wild-type calvaria and
predictably absent in Osx-null calvaria. Likewise, osteocalcin
expression, a marker of mature osteoblasts, was dramatically
reduced in Osx-null calvaria compared to wild-type tissue. In
contrast, Runx2, a gene that is upstream of Osx in the osteoblast
differentiation pathway, was unchanged in the Osx-null calvaria.
Figure 6. Identification of the Osx binding site in the promoter
of VDR gene. (A) Deletion analysis of the VDR promoter-reporter
construct. VDR-1 kb, VDR-500 bp, VDR-250 bp and VDR-120 bp pro-
moter-reporter plasmids (300 ng each) were cotransfected with 400 ng
of the Osx expression plasmid in HEK293 cells. Twenty-four hours post-
transfection, cell extracts were prepared and analyzed for luciferase
activity and normalized to b-galactosidase activity. (B) Two GC-rich
elements in VDR-120 are responsible for VDR promoter reporter
activation by Osx. The promoter mutants VDR-M1, VDR-M2 and VDR-
M12 were transfected into HEK293 cells and analyzed as described in
panel A. Luciferase activity was normalized by b-galactosidase activity.
(C) A diagram of the proximal 120 bp region of the mouse VDR
promoter. A 59 primer and 39 primer were used to subclone the VDR-
120 bp promoter reporter plasmid. M1 refers to point mutations of
VDR-M1, and M2 refers to point mutations of VDR-M2. VDR-M12 in (B)
contains both M1 and M2.
doi:10.1371/journal.pone.0026504.g006
Figure 7. Endogenous Osx in primary osteoblasts is associated
with the native VDR promoter in vivo. Chromatin Immunoprecip-
itation (ChIP) assays were conducted using primary calvarial osteoblasts
isolated from new born wild-type mice. Anti-Osx antibody (a-Osx) was
used for ChIP analysis, and IgG was used as a negative control. The
precipitated chromatin was analyzed by quantitative real-time PCR. As
described in the Methods, primer Set 1 corresponds to a segment
covering two GC-rich elements within 120 bp the VDR promoter. As a
negative control, Primer Set 2 covers a distal 3 kb region of the VDR
promoter, which does not contain GC-rich sequences. A paired t-test
was performed comparing IgG and a-Osx group.
doi:10.1371/journal.pone.0026504.g007
Osx Regulates VDR Positively
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e26504Interestingly, we observed that VDR expression was suppressed by
greater than 70-fold in Osx-null calvaria compared with that in
wild-type calvaria. The significant decrease in VDR RNA level in
Osx knock-out mice suggests that Osx regulates VDR gene
expression.
Overexpression of Osx activates VDR gene expression
To test whether forced expression of Osx stimulated VDR gene
expression, we used a stable, Osx-inducible C2C12 mesenchymal
cell line that was described previously [7]. In this line, expression
of Osx is dramatically induced upon removal of doxycycline
(Dox)(Fig. 2A). Total RNA was purified from this line following
culture in the presence or absence of Dox and VDR expression was
quantitated by real-time RT-PCR. As shown in Fig. 2B, in the
absence of Dox (i.e., overexpression of Osx), VDR expression was
enhanced 5.5 fold. In this cell system, ectopic Osx expression also
coincides with the expression of osteoblast marker genes ALP
(Fig. 2C) and osteocalcin (OC; Fig. 2D). These data indicate that
increased expression of Osx results in increased expression of
VDR and osteoblastic marker genes in the C2C12 system.
Inhibition of Osx by siRNA reduces VDR gene expression
in osteoblasts
To establish a direct effect of Osx on VDR expression, we used
siRNA to knockdown Osx expression in MC3T3 osteoblast cells.
MC3T3 cells were chosen for this approach because they express
higher, more readily detected levels of Osx and VDR. Real-time
RT-PCR and western-blots were performed to analyze mRNA
and protein expression levels, respectively. As shown in Fig. 3A,
when Osx RNA expression was decreased by 80% using siRNA
targeted against Osx, VDR RNA levels were reduced by
approximately 42%. The decrease in VDR expression mediated
by Osx-knockdown was also evident at the protein level as
depicted in Fig. 3B. Therefore, these data support a role for Osx in
enhancing VDR gene expression in osteoblasts.
Osx gene expression is independent VDR in vivo
To test whether a complementary relationship exists, that is,
whether Osx is affected by VDR status in vivo, we examined Osx
gene expression levels in wild-type and VDR-null E18.5 calvaria.
As shown in Fig. 4, VDR expression was undetectable in VDR-null
calvaria as expected. Osx expression levels remained unchanged in
the absence of VDR. These data support the concept that Osx is
an upstream gene of VDR.
Osx activates the murine VDR promoter through GC-rich
regions in the immediate 59 region
Results from primary mouse calvarial cells, the stable C2C12
mesenchymal cell line and the MC3T3 osteoblastic cell line
strongly indicate that Osx upregulates VDR gene expression. To
test whether this is a direct effect of Osx on the VDR promoter, we
generated a luciferase reporter construct driven by 1 kb of 59-
flanking sequence from the native, murine VDR promoter. This
construct was cotransfected with different amounts of an Osx
expression plasmid (pEX-Osx) into HEK293 cells. As illustrated in
Fig. 5, increasing amounts of the Osx expression plasmid resulted
in increased levels of VDR promoter-reporter activity in this cell
system. To define the precise Osx regulatory region in the VDR
promoter, we generated a series deletion constructs of the VDR
promoter reporter and tested them in our HEK293 transfection
assay. As shown in Fig. 6A, Osx activated all of the VDR promoter
reporters similarly, including the VDR-1 kb, VDR-500 bp, VDR-
250 bp and VDR-120 bp constructs. These data indicate that the
putative regulatory or binding elements for Osx reside within the
VDR 120 bp promoter region. Previous studies show that Osx
belongs to the Sp/XKLF family of transcription factors that bind
to GC-rich sequences of target gene promoters to regulate gene
expression [4]. Sequence analysis of the active 120 bp region of
VDR promoter reveal two potential, GC-rich binding sites for Osx
located at positions 251–245 and 235–229, relative to the
transcriptional start site. To study which binding site is responsible
for VDR promoter activation by Osx, we disrupted each element
by site-directed mutagenesis. The two mutants were designated
VDR-M1 and VDR-M2 in which the guanines (Gs) in each
element were replaced with adenines (As) (Fig. 6C). As shown in
Fig. 6B, Osx activation of the M1 and M2 VDR promoter mutants
was only 42% and 53% respectively, that of the wild-type VDR-
120 bp promoter. Finally, we generated a double mutant in which
both GC-rich elements were disrupted (VDR-M12). As shown in
Fig. 6B, Osx expression only modestly activated this double
mutation (,2-fold). Cumulatively, these data revealed that the two
GC-rich sequences residing between 251 and 229 relative to the
transcriptional start site, function as Osx-responsive elements that
mediate the activation of the VDR promoter by Osx.
Figure 8. Osx-regulated expression of VDR is important in Osx-induced osteoblast differentiation. (A) SiRNA directed against VDR
knocks down VDR expression. C2C12 mesenchymal cells stably expressing Osx were transfected with VDR siRNA at different concentrations. RNA was
isolated and specific RNA levels were measured by real-time RT-PCR. (B,C) Cells were transfected with 300 nM of siRNA targeting VDR, and Osx
expression was induced by removing Dox. Osteoblast marker gene expression was examined including (B) ALP and (C)osteocalcin (OC). The RNA level
from control siRNA group (Si-C) was normalized to a value of 1. Values were presented as the mean 6S.D. *: A star indicates statistical significance
compared to Dox (+) group (p,0.05). **: Two stars indicate statistical significance compared to si-control (Si-C) (p,0.05). (D) Western analysis of the
VDR knockdown. C2C12 stable cells without Dox were transfected with 300 nM of siRNA targeting VDR. Protein was isolated from whole cell lysates
of control siRNA group (si-C) and VDR siRNA group (si-VDR) and then analyzed by western blot using rabbit anti-VDR, anti-ALP or anti-OC polyclonal
antibodies. Beta-actin was used as a loading control.
doi:10.1371/journal.pone.0026504.g008
Osx Regulates VDR Positively
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promoter in vivo
The studies above indicate that Osx can positively regulate
VDR expression and activate the VDR promoter in vitro through
two GC-rich sequences in VDR promoter. However, it is currently
unknown whether endogenous Osx associates with the native VDR
promoter in vivo. To address this question, chromatin immuno-
precipitation (ChIP) assays were carried out to examine whether
Osx could bind to native VDR promoter in primary calvarial
osteoblasts isolated from new born wild-type mice. Crosslinked
extracts were immunoprecipitated with antibodies against Osx or
control IgG. Following reversal of the crosslinks, DNA was
recovered and analyzed by quantitative real time PCR using
primers designed to amplify the Osx-responsive region covering
the two GC-rich sequences of VDR-120 bp promoter (Primer Set
1) or a distal upstream 3 kb, non-responsive region (Primer Set 2)
as a control to demonstrate response element selectivity. Fig. 7
demonstrated that Osx was associated with the VDR promoter
region containing the two GC-rich sequences (Primer Set 1)
compared with IgG control group. However, Osx was not
associated with the VDR distal 3 kb promoter region lacking a
GC-rich sequence (Primer Set 2), demonstrating that the observed
Osx-DNA association was specific. Thus, these data indicate that
endogenous Osx associates with the native VDR promoter in
primary osteoblasts in vivo.
VDR is involved in Osx-induced osteoblast differentiation
To determine if VDR gene regulation by Osx is important for
appropriate control of osteoblastic gene expression, we tested the
effects of VDR siRNA on Osx-induced osteoblast marker gene
expression. Using our Tet-off C2C12 mesenchymal cell line, we
observed that forced expression of Osx dramatically induced
osteoblast marker gene expression, including ALP and osteocalcin
(Fig. 8). siRNA against VDR reduced VDR expression signifi-
cantly (66% at 300 nM, Fig. 8A). Importantly, VDR siRNA
significantly inhibited Osx-induced expression of ALP and OC
(Fig. 8B and C). The decreases in ALP and OC expression
mediated by VDR-knockdown were also evident at the protein
level as shown in Fig. 8D. These data suggest that the regulated
expression of VDR by Osx is important for appropriate expression
of osteoblastic marker genes. They further support our hypothesis
that VDR is an important downstream target gene of Osx, and
may participate in the regulation of critical genes involved in
osteoblast differentiation and development.
To examine the coordinate expression of Osx and VDR during
osteoblast differentiation, preosteoblastic MC3T3-E1 cells were
cultured in osteogenic media containing BMP2, ascorbic acid and
b–glycerophosphate. Cells were harvested at various times
following the addition of osteogeneic media. RNA was isolated
from cell lysates, and analyzed by realtime RT-PCR. As shown in
Fig. 9, both Osx and VDR expression were significantly enhanced
throughout this early phase of osteoblast differentiation at times
when early osteoblastic markers such as alkaline phosphatase
increased (data not shown). These data show that both Osx and
VDR are coordinately upregulated during osteoblast differentia-
tion.
Discussion
Osx is an osteoblast-specific transcription factor that controls
the expression of essential genes needed for appropriate osteoblast
differentiation and function. Despite the discovery of its signifi-
cance in skeletal physiology a decade ago [4], relatively little is
known about direct target genes for Osx and molecular
mechanisms through which Osx regulates transcription. The
findings presented here provide important, new insights into these
two general, poorly understood areas of Osx biology.
First, we identified VDR as an Osx target gene. This is
supported by the Osx-directed gene expression studies showing
coordinate expression of Osx and VDR in several in vivo and in vitro
model systems. For example, Osx-null calvaria displayed defective
in vivo expression of VDR compared to wild-type calvaria in mice.
Primary osteoblast cultures obtained from wild-type calvaria also
had markedly impaired VDR gene expression when Osx
expression was knocked-down using siRNA targeting strategies
(Fig. 3) and a Tet-off inducible cell system revealed that ectopic
expression of Osx resulted in an increase in VDR transcript level
(Fig. 2B). Importantly, a direct regulation of VDR gene
transcription by Osx was evident in the ability of recombinant
Figure 9. Both Osx and VDR are upregulated during osteoblast
differentiation. MC3T3 osteoblast differentiation experiments were
performed in which osteogenic factors were added into the medium,
including BMP2, ascorbic acid and b–glycerophosphate. MC3T3
osteoblastic cells were harvested after 0 hr, 8 hr, 24 hr, 72 hr and
104 hr after incubating with differentiation medium. RNA was isolated
from cell lysates. RNA levels for VDR and Osx were analyzed by real-time
RT-PCR. The level of RNA from 0 hr was normalized to a value of 1.
Values were presented as the mean 6S.D.
doi:10.1371/journal.pone.0026504.g009
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ing that the RNA expression studies were likely due to the effects
of Osx expression on VDR gene transcription. The broader
implication of these studies is that the VDR gene can now be
added to a small, but growing list of osteoblastogenic factors and
pathways that are regulated by Osx in the osteoblast [7,24,25].
In terms of mechanism, Osx is an SP/KLF family member that
presumably functions by binding directly to DNA promoter
elements via an SP1-like DNA-binding domain consisting of three
C2H2-type zinc fingers located within its C-terminus [4]. While
consensus Osx-binding DNA elements have not been rigorously
defined as yet, they likely are GC-rich in nature based on the
similarities of DNA-binding domains and elements among this
family of transcription factors. We previously reported on similar
elements controlling Osx-activation of the DKK1 and sclerostin
promoters [7,24]. Indeed, two such GC-rich regions exist in the
most proximal regions of the murine VDR promoter residing
immediately adjacent to its transcriptional start site [22].
Importantly, our studies define these two elements as critical for
mediating the transcriptional activation of the VDR promoter by
Osx. Mutation of each element (M1 or M2) reduced Osx-directed
activation of the VDR promoter by approximately 50% and
mutation of both elements nearly abolished the response (Fig. 6B).
Of course, limitations of this particular approach include the
heterologous expression and somewhat artificial nature of the
plasmid DNA constructs used as a measure of a biologically
relevant transcriptional event. Thus, the chromatin immunopre-
cipitation approaches (Fig. 7) strongly support the reporter gene
expression data. These studies clearly demonstrated that endog-
enous Osx was associated with the GC-rich proximal region of the
native VDR promoter in primary osteoblastic cells. These studies
help establish Osx mechanisms involving direct binding of Osx to
sequence specific, GC-rich promoter elements to activate the
expression of genes in osteoblastic cells.
Osx is considered as a master regulator of osteoblast
differentiation [4,7]. Unfortunately, the cellular and molecular
mechanisms governing Osx control of osteoblast differentiation
and function are still not well characterized. Osx is known to
function downstream of Runx2 during osteoblast differentiation
[4,26] and Osx is required for the expression of osteoblast-specific
markers, such as type I collagen, osteocalcin, bone sialoprotein,
osteonectin and osteopontin [4]. Interestingly, several of these
genes are also regulated by VDR and 1,25-(OH)2D3 in the
osteoblast [15,16]. This fact, combined with our observation that
VDR is an Osx target gene, strongly suggests that potential
interplays between Osx and VDR in osteoblast gene expression,
differentiation and/or function need to be explored in more detail
in the future. Clearly, 1,25-(OH)2D3 and VDR have complex,
seemingly disparate, roles depending on early versus late stages of
osteoblast differentiation [17]. In early or preosteoblastic stages,
1,25-(OH)2D3 treatment suppresses type I collagen and alkaline
phosphatase mRNA levels, while both genes are elevated by 1,25-
(OH)2D3 in late-stage osteoblast differentiation. VDR and 1,25-
(OH)2D3 directly inhibit the differentiation and function of early
stage osteoblasts [27,28], but enhances the activity of terminally
differentiated osteoblasts [19,29]. While its precise role is
unresolved, our studies clearly indicate that Osx-directed regula-
tion of VDR expression is a biologically relevant process that is
needed for appropriate expression of osteoblastic cell marker
genes. This is evident from the siRNA-mediated knockdown of
VDR protein levels in the C2C12 model system (Fig. 8). Here,
interfering with Osx-mediated induction of VDR gene expression
interfered with the appropriate expression of alkaline phosphatase
and osteocalcin, two of the most relevant biological markers of
osteoblasts. Thus, while additional studies need to address other
cell systems and the ultimate effects of Osx and VDR regulation
on the full osteoblastic cell differentiation pathway progressing to
the stage of mineralized matrix production, these early stage
studies provide a sound biological context and relevance for Osx
activation of VDR gene expression in this model system.
Most current therapeutic strategies for low bone density
disorders such as osteoporosis focus on suppressing bone
resorption. However, the main limitation of this approach is that
the rate of bone loss is slowed, but not reversed. Thus, anabolic
strategies targeting osteoblastic pathways and the stimulation of
bone formation are highly desirable. Continued progress on Osx
and downstream targets/pathways under its control will help
determine the relevance of this system as an anabolic therapeutic
targeting strategy to combat osteoporosis and other bone related
diseases.
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